University of South Carolina publications. Series 3. Biology. V.1 No.1

This publication is volume 1, issue 1 of the University of South Carolina Publications. Series III. Biology. on taxonomic studies of the flora and fauna of South Carolina.

University of South Carolina publications. Series 3. Biology. V.1 No.2

This publication is volume 1, issue 2 of the University of South Carolina Publications. Series III. Biology. on taxonomic studies of the flora and fauna of South Carolina.

University of South Carolina publications. Series 3. Biology. V.1 No.3

This publication is volume 1, issue 3 of the University of South Carolina Publications. Series III. Biology. on taxonomic studies of the flora and fauna of South Carolina.

University of South Carolina publications. Series 3. Biology. V.1 No.5

This publication is volume 1, issue 5 of the University of South Carolina Publications. Series III. Biology. on taxonomic studies of the flora and fauna of South Carolina.

University of South Carolina publications. Series 3. Biology. V.2 No.1

This publication is volume 2, issue 1 of the University of South Carolina Publications. Series III. Biology. on taxonomic studies of the flora and fauna of South Carolina.

University of South Carolina publications. Series 3. Biology. V.2 No.2

This publication is volume 2, issue 2 of the University of South Carolina Publications. Series III. Biology. on taxonomic studies of the flora and fauna of South Carolina.

University of South Carolina publications. Series 3. Biology. V.2 No.4

This publication is volume 2, issue 4 of the University of South Carolina Publications. Series III. Biology. on taxonomic studies of the flora and fauna of South Carolina.

University of South Carolina publications. Series 3. Biology. V.1 No.4

This publication is volume 1, issue 4 of the University of South Carolina Publications. Series III. Biology. on taxonomic studies of the flora and fauna of South Carolina.

University of South Carolina publications. Series 3. Biology. V.2 No.3

This publication is volume 2, issue 3 of the University of South Carolina Publications. Series III. Biology. on taxonomic studies of the flora and fauna of South Carolina.

University of South Carolina publications. Series 3. Biology. V.3 No.1

This publication is volume 3, issue 1 of the University of South Carolina Publications. Series III. Biology. on taxonomic studies of the flora and fauna of South Carolina.

Graphene Oxide: A Carrier For Pharmaceuticals And A Scaffold For Cell Interactions.

During the last ten years, graphene oxide has been explored in many applications due to its remarkable electroconductivity, thermal properties and mobility of charge carriers, among other properties. As discussed in this review, the literature suggests that a total characterization of graphene oxide must be conducted because oxidation debris (synthesis impurities) present in the graphene oxides could act as a graphene oxide surfactant, stabilizing aqueous dispersions. It is also important to note that the structure models of graphene oxide need to be revisited because of significant implications for its chemical composition and its direct covalent functionalization. Another aspect that is discussed is the need to consider graphene oxide surface chemistry. The hemolysis assay is recommended as a reliable test for the preliminary assessment of graphene oxide toxicity, biocompatibility and cell membrane interaction. More recently, graphene oxide has been extensively explored for drug delivery applications. An important increase in research efforts in this emerging field is clearly represented by the hundreds of related publications per year, including some reviews. Many studies have been performed to explore the graphene oxide properties that enable it to deliver more than one activity simultaneously and to combine multidrug systems with photothermal therapy, indicating that graphene oxide is an attractive tool to overcome hurdles in cancer therapies. Some strategic aspects of the application of these materials in cancer treatment are also discussed. In vitro studies have indicated that graphene oxide can also promote stem cell adhesion, growth and differentiation, and this review discusses the recent and pertinent findings regarding graphene oxide as a valuable nanomaterial for stem cell research in medicine. The protein corona is a key concept in nanomedicine and nanotoxicology because it provides a biomolecular identity for nanomaterials in a biological environment. Understanding protein corona-nanomaterial interactions and their influence on cellular responses is a challenging task at the nanobiointerface. New aspects and developments in this area are discussed.

Síndrome de Down e Moyamoya: estudo através de metanálise

We present a clinic-epidemiological study of two patients and meta-analysis (period 1977-2000 ) of the co-morbidity of the Down syndrome (DS) and moyamoya syndrome (MMS). Among the 42 patients listed in this survey, meta-analysis permitted to find the highest number of publications by researchers from Japan and United States, followed by Brazil and Italy; prevalence of cerebrovascular disease in suckling and pre school children; first symptomatology was hemiparesis (78.6%), speech disorders (26.2%); ischemic infarction (76.2%); recurring ischemic episodes (62%); bilateral impairment (83.3%). This analysis led to the conclusion that in the clinic-neurological investigation of DS patients with acute hemiparesis episodes, MMS should be included as the most probable diagnosis.

Polímeros biomiméticos em química analítica. Parte 2: aplicações de MIP (Molecularly Imprinted Polymers) no desenvolvimento de sensores químicos

The aim of this paper is the description of the strategies and advances in the use of MIP in the development of chemical sensors. MIP has been considered an emerging technology, which allows the synthesis of materials that can mimic some highly specific natural receptors such as antibodies and enzymes. In recent years a great number of publications have demonstrated a growth in their use as sensing phases in the construction of sensors . Thus, the MIP technology became very attractive as a promising analytical tool for the development of sensors.

Atypical antipsychotics in the treatment of pathological aggression in children and adolescents: literature review and clinical recommendations

Objective: To review the literature about the use of atypical antipsychotics in the treatment of pathological aggression in children and adolescents. Method: The databases MEDLINE, SciELO, and LILACS were searched for publications in Portuguese or English from 1992 to August 2011 using the following keywords: mental disease, child, adolescent, treatment, atypical antipsychotic, aggressive behavior, aggression, and violent behavior. Results: Sixty-seven studies of good methodological quality and clinical interest and relevance were identified. Studies including children and adolescents were relatively limited, because few atypical antipsychotics have been approved by the Food and Drug Administration (FDA). All the medications included in this review (risperidone, olanzapine, quetiapine, ziprasidone, aripiprazole and clozapine) have some effectiveness in treating aggression in children and adolescents, and choices should be based on clinical indications and side effects. Conclusions: There are few studies about the effectiveness and safety of atypical antipsychotics for the pediatric population, and further randomized controlled studies with larger groups of patients and more diagnostic categories, such as severe conduct disorder and oppositional defiant disorder, should be conducted to confirm the results reported up to date and to evaluate the impact of long-term use.